SEARCH

SEARCH BY CITATION

References

  • Biernaskie JA, McKenzie IA, Toma JG, Miller FD (2006) Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny. Nat Protoc 1: 2803- 2812
  • Biernaskie J, Paris M, Morozova O, Fagan BM, Marra M, Pevny L, Miller FD (2009) SKPs Derive from Hair Follicle Precursors and Exhibit Properties of Adult Dermal Stem Cells. Cell Stem Cell 5: 610- 623
  • Bodden WL, Palayoor ST, Hait WN (1986) Selective antimitochondrial agents inhibit calmodulin. Biochem Biophys Res Commun 135: 574- 582
  • Brideau C, Gunter B, Pikounis B, Liaw A (2003) Improved statistical methods for hit selection in high-throughput screening. J Biomol Screen 8: 634- 647
  • Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC et al (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118: 3065- 3074
  • Christman JE, Miller DS, Coward P, Smith LH, Teng NN (1990) Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies. Gynecol Oncol 39: 72- 79
  • Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267- 284
  • De Preter K, De Brouwer S, Van Maerken T, Pattyn F, Schramm A, Eggert A, Vandesompele J, Speleman F (2009) Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds. Clin Cancer Res 15: 3690- 3696
  • Fernandes KJL, McKenzie IA, Mill P, Smith KM, Akhavan M, Barnabe-Heider F, Biernaskie J, Junek A, Kobayashi NR, Toma JG et al (2004) A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 6: 1082- 1093
  • Frank NY, Schatton T, Frank MH (2010) The therapeutic promise of the cancer stem cell concept. J Clin Invest 120: 41- 50
  • Galeano E, Nieto E, Garcia-Perez AI, Delgado MD, Pinilla M, Sancho P (2005) Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines. Mitochondrial implication in cell death. Leuk Res 29: 1201- 1211
  • Gheeya JS, Chen QR, Benjamin CD, Cheuk AT, Tsang P, Chung JY, Metaferia BB, Badgett TC, Johansson P, Wei JS et al (2009) Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma. Cancer Biol Ther 8: 2386- 2395
  • Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, Holyoake TL (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99: 319- 325
  • Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12: 9- 22
  • Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS, Smith KM, Look AT, Yeger H, Miller FD et al (2007) Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 67: 11234- 11243
  • Johnsen JI, Segerstrom L, Orrego A, Elfman L, Henriksson M, Kagedal B, Eksborg S, Sveinbjornsson B, Kogner P (2008) Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Oncogene 27: 2910- 2922
  • Konig H, Holtz M, Modi H, Manley P, Holyoake TL, Forman SJ, Bhatia R (2008) Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia 22: 748- 755
  • Laverdiere C, Liu Q, Yasui Y, Nathan PC, Gurney JG, Stovall M, Diller LR, Cheung N.-K, Wolden S, Robison LL et al (2009) Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study. J Natl Cancer Inst 101: 1131- 1140
  • Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278: 8516- 8525
  • Marimpietri D, Brignole C, Nico B, Pastorino F, Pezzolo A, Piccardi F, Cilli M, Di Paolo D, Pagnan G, Longo L et al (2007) Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis. Clin Cancer Res 13: 3977- 3988
  • Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369: 2106- 2120
  • Martel RR, Klicius J, Galet S (1977) Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 55: 48- 51
  • Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM et al (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 341: 1165- 1173
  • Misawa A, Hosoi H, Tsuchiya K, Sugimoto T (2003) Rapamycin inhibits proliferation of human neuroblastoma cells without suppression of MycN. Int J Cancer 104: 233- 237
  • Pampaloni F, Reynaud EG, Stelzer EHK (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8: 839- 845
  • Qin D, Sullivan R, Berkowitz WF, Bittman R, Rotenberg SA (2000) Inhibition of protein kinase C(alpha) by dequalinium analogues: dependence on linker length and geometry. J Med Chem 43: 1413- 1417
  • Reynolds BA, Rietze RL (2005) Neural stem cells and neurospheres-re-evaluating the relationship. Nat Methods 2: 333- 336
  • Reynolds CP, Biedler JL, Spengler BA, Reynolds DA, Ross RA, Frenkel EP, Smith RG (1986) Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 76: 375- 387
  • Rotenberg SA, Smiley S, Ueffing M, Krauss RS, Chen LB, Weinstein IB (1990) Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium. Cancer Res 50: 677- 685
  • Sancho P, Galeano E, Nieto E, Delgado MD, Garcia-Perez AI (2007) Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production. Leuk Res 31: 969- 978
  • Schneider Berlin KR, Ammini CV, Rowe TC (1998) Dequalinium induces a selective depletion of mitochondrial DNA from HeLa human cervical carcinoma cells. Exp Cell Res 245: 137- 145
  • Sehgal SN, Baker H, Vezina C (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot (Tokyo) 28: 727- 732
  • Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432: 396- 401
  • Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3
  • Sorensen AG, Patel S, Harmath C, Bridges S, Synnott J, Sievers A, Yoon Y-H, Lee EJ, Yang MC, Lewis RF et al (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19: 551- 557
  • Sullivan RM, Stone M, Marshall JF, Uberall F, Rotenberg SA (2000) Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells. Mol Pharmacol 58: 729- 737
  • Thiele CJ (1998) Neuroblastoma. In: Human Cell Culture, Masters J. R. W, Palsson B. (eds), Lancaster, UK, Kluwer Academic Publishers: pp 21- 53
  • Toma J, Akhavan M, Fernandes K, Barnabe-Heider F, Sadikot A, Kaplan D, Miller F (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3: 78- 784
  • Toma JG, McKenzie IA, Bagli D, Miller FD (2005) Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23: 727- 737
  • Ward RJ, Dirks PB (2007) Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol 2: 175- 189
  • Weiss MJ, Wong JR, Ha CS, Bleday R, Salem RR, Steele GD, Chen LB (1987) Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proc Natl Acad Sci 84: 5444- 5448
  • Wright RGM, Wakelin LPG, Fieldes A, Acheson RM, Waring MJ (1980) Effects of ring substituents and linker chains on the bifunctional intercalation of diacridines into deoxyribonucleic acid. Biochemistry 19: 5825- 5836
  • Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471- 484
  • Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475- 482
  • Zhang J.-H, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4: 67- 73
  • Zhuo S, Allison WS (1988) Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequalinium. Biochem Biophys Res Commun 152: 968- 972